Board meeting on October 29 to consider and approve September quarter and half year results
Bharat Parenterals has informed the exchanges that its Board of Directors will meet on Thursday, October 29, 2026.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Thursday, October 29, 2026
- Period Covered
- quarter and half year ended September 30, 2026
- Trading Window Closed From
- Thursday, October 01, 2026 until 48 hours after the results are declared
What the update says
Bharat Parenterals has told BSE that a meeting of its Board of Directors is scheduled for Thursday, October 29, 2026, at the registered office. The stated purpose is to consider, approve and take on record the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended September 30, 2026, and to consider any other business with the permission of the Chair.
- Two sets of numbers are on the agenda: standalone and consolidated.
- The period covered is both the quarter and the half year ended September 30, 2026.
- The results are described as unaudited.
- Board approval is the step before the results are declared to the exchanges.
Trading window
The company also stated that the trading window for dealing in its securities is closed for all designated persons and their immediate relatives. The closure has been in force since Thursday, October 01, 2026 and continues until 48 hours after the financial results are declared.
This is a standard insider-trading safeguard around results announcements: people inside the company may hold price-sensitive information before the numbers go public, so they are barred from trading in the shares during that window.
What a retail investor can take away
- A results date is now known, so the next scheduled information event for the company is the September quarter and half year numbers.
- The update itself contains no financial figures, revenue, profit, margin or dividend information; it is a scheduling notice.
- Board approval and declaration of results are the steps to watch; the numbers themselves will come separately.
Points to keep in mind
- The trading window closure applies to designated persons, not to the general investing public.
- The notice states that the same intimation is available on the company's website.
Also from Bharat Parenterals
Shareholders approve preferential share issue and higher Section 186(2) limits
24 Oct 2026
Bharat Parenterals schedules Q2 & H1FY27 earnings conference call for October 30, 2026
24 Oct 2026
EGM summary: preferential equity issue and Section 186 limit approval among 2 special resolutions
23 Oct 2026
More numbers
- Trading window closure period after results are declaredForty-eight (48) hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.